Brookdale Senior Living Inc.

NYSE:BKD

Medical - Care Facilities

Healthcare
$8.59 +0.33%

+$0.05 today

Market cap
$2.06B
Beta
0.62
P/E (TTM)
-15.9
EPS (TTM)
-$0.86
52W Low $6.65High $17.09

Volume 4.89M

Average 3.63M

BKD Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Brookdale Senior Living Inc.NYSE: BKD

Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026

Capital expenditures growth accelerates

Q3 FY2026 capital expenditures of $59.15M (cash outflow) rose 42.2% year over year, ahead of the +15.7% change in trailing-twelve-month capital expenditures. Sequentially, it rose 22.2% from the prior quarter. Over 3 fiscal years it compounded at +0.8% a year.

Context

  • Capital expenditures amounted to 6.4% of revenue in FY2025, down 0.3 pp from a year earlier.
  • Capital expenditures grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +42.2% holds above the trailing-twelve-month pace of +15.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$59.15M+22.2% QoQ
Last fiscal yearDec 2025
-$201.53M+0.5% YoY
LTMSep 2026
-$217.71M+15.7% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+42.2%——
1 year+0.5%——
3-year CAGR+0.8%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(201.53M) USD
Year-over-year change
-0.5%

Capital Expenditures vs competitors

How BKD compares with its peers on the latest reported figures

  • BKD's LTM Sep 2026 capital expenditures of $217.71M is the largest of the 10 companies compared; the peer median is $9.34M.
  • Its year-over-year change of +15.7% is the 8th highest of 10, against a peer median of +38.1%.
  • Capital expenditures amounts to 7.4% of revenue for BKD, versus a peer median of 1.9%.
BKD Competitors Peer median
Capital Expenditures for BKD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BKDBrookdale Senior Living Inc.LTM Sep 2026$217.71M +15.7%+0.8%7.4%
ARDTArdent Health Partners, LLCLTM Mar 2026$217.08M +16.4%+11.9%3.4%
NHCNational HealthCare CorporationLTM Sep 2026$46.05M +34.6%+6.5%2.9%
ACHCAcadia Healthcare Company, Inc.LTM Sep 2026$21.93M +103.2%+24.5%0.6%
AVAHAveanna Healthcare Holdings Inc.LTM Oct 2026$9.7M +38.1%-14.7%0.4%
IBRXImmunityBio, Inc.LTM Sep 2026$9.53M +87.3%-63.4%5.2%
ADUSAddus HomeCare CorporationLTM Jun 2026$9.34M +38.1%-2.4%0.6%
DNLIDenali Therapeutics Inc.LTM Jun 2026$3.42M -81.4%-18.9%94.8%
COGTCogent Biosciences, Inc.LTM Jun 2026$1.7M +64.1%-39.0%—
RCUSArcus Biosciences, Inc.LTM Jun 2026$1M -66.7%-30.7%0.9%
Peer median (excluding BKD) $9.34M+38.1%-14.7%1.9%

Competitors are the stored peer set for BKD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(99.36M)(238.34M)(189.01M)(201.99M)(262.75M)
Depreciation & Amortization345.06M353.89M350.41M367.51M370.3M
Deferred Income Tax(9.84M)(1.32M)7.59M3.62M(3.29M)
Stock-Based Compensation16.27M14.47M11.99M14.18M11.94M
Change in Working Capital(50.49M)(41.27M)40.65M12.22M1.2M
Accounts Receivables502K(4.62M)7.38M(3.5M)(15.79M)
Inventory54.03M0000
Accounts Payables(54.03M)(27.19M)2.45M15.7M0
Other Working Capital(51M)(9.46M)30.82M23K16.99M
Other Non-Cash Items(296.27M)(84.15M)(58.7M)(29.36M)100.63M
Operating Cash Flow(94.63M)3.28M162.92M166.18M218.03M
Capital Expenditures(176.66M)(196.92M)(233.21M)(200.61M)(201.53M)
Acquisitions (Net)(5.44M)(218K)(7.59M)(101.39M)0
Purchases of Investments(362.26M)(263.67M)(186.93M)(49.69M)(3.83M)
Sales of Investments352.99M398.75M206.99M80.56M25.63M
Other Investing Activities372.82M(5.37M)107.94M(6.93M)(276.23M)
Investing Cash Flow181.46M(67.43M)(113.36M)(278.07M)(455.95M)
Debt Repayment(88.61M)(26.93M)(161.69M)170.66M225.71M
Common Stock Issued0139.44M000
Common Stock Repurchased(4.82M)0(1.92M)(3.44M)(6.47M)
Dividends Paid00000
Other Financing Activities(20.23M)131.6M(10.83M)(25.16M)(18.15M)
Financing Cash Flow(113.66M)100.38M(174.44M)142.06M201.09M
Effect of Forex Changes00000
Net Change in Cash(26.83M)36.23M(124.88M)30.17M(36.83M)
Free Cash Flow(271.29M)(193.64M)(70.28M)(34.44M)16.51M

Brookdale Senior Living Inc.

NYSE:BKD

Intrinsic Alpha fair value

Locked

Current Price

$8.59

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.